The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Extended survival analysis of ipilimumab for the treatment of advanced malignant melanoma in pretreated patients: Five-year long-term follow-up of the South African expanded access program.
 
Bernardo Leon Rapoport
Honoraria - Merck; Tesaro
Consulting or Advisory Role - Bristol-Myers Squibb; Merck; Tesaro
Speakers' Bureau - Merck; Tesaro
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Tesaro
 
Daniel A. Vorobiof
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Roche
Travel, Accommodations, Expenses - Amgen
 
Lydia Mary Dreosti
Honoraria - Janssen; Merck; Roche
Consulting or Advisory Role - Janssen; Merck
Speakers' Bureau - Janssen
Research Funding - Novartis
Travel, Accommodations, Expenses - Janssen; Merck; Roche
 
Adam L. Nosworthy
Stock and Other Ownership Interests - Discovery Holdings
Honoraria - Janssen; Key Oncologics
 
Georgina Laird McAdam
No Relationships to Disclose
 
Johann Petrus Jordaan
Speakers' Bureau - Merck
Research Funding - Ipsen; Novartis; Parexel; Quintiles; Roche
Travel, Accommodations, Expenses - Roche
 
Helen Miller-Janson
Consulting or Advisory Role - TCD Outcomes Research (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
 
Janetta Catharina de Beer
Consulting or Advisory Role - TCD Outcomes Research (Inst)
Research Funding - Bristol-Myers Squibb (Inst)
 
Margreet de Necker
Consulting or Advisory Role - TCD Outcomes Research (Inst)
Research Funding - Bristol-Myers Squibb (Inst)